Katapult Holdings, Inc. (NASDAQ: KPLT), an e-commerce-focused financial technology company, today announced gross originations for the fourth quarter ended ...
Phase 2 clinical study of firicabtagene autoleucel (firi-cel); Interim analysis results expected to be reported in 1H'25 - - IND application for CRG-023 ...